-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Kiniksa Pharmaceuticals International, plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2017 to Q2 2024.
- Kiniksa Pharmaceuticals International, plc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $7.36M, a 13.7% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $29.1M, a 16.5% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc annual Share-based Payment Arrangement, Expense for 2023 was $27.1M, a 8.08% increase from 2022.
- Kiniksa Pharmaceuticals International, plc annual Share-based Payment Arrangement, Expense for 2022 was $25.1M, a 0.21% decline from 2021.
- Kiniksa Pharmaceuticals International, plc annual Share-based Payment Arrangement, Expense for 2021 was $25.2M, a 20.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)